In this issue:
Covalent targeted radioligands
ADT + postoperative radiotherapy for prostate cancer
Duration of ADT + postoperative radiotherapy for prostate cancer
PSA screening and 15-year prostate cancer mortality
Prognostic impact of PSA 6 months after radiotherapy
Multivitamins and prostate cancer survival
Psoas muscle mass predictor for mCSPC
PSA response to ADT in the neoadjuvant setting
Salvage treatment of oligorecurrent nodal prostate cancer metastases
Plant-based diet and prostate cancer disease progression
Please login below to download this issue (PDF)